open-burger-menu
Search Icon
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
📈 NEW Report: Abortions, Tax Funding UP at Planned Parenthood >>
Search Icon
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

close-panel
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Research Type:

Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research

Sort 1464 results by:

Filter results further
Filter Applied. Clear All

Latest Posts

October 6, 2026 A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Inside The Government Decision That Opened Up Abortion Pill Floodgates Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Research Type
Publication Type
By State
See All
By Author
See All
Reset All Filters

Did You Know ?

Did You Know ?

In the fourth week, the embryonic heart starts beating. The neural tube, which becomes the brain and spinal cord, forms. At this point, a woman has likely only been aware of her pregnancy for one week.

Did You Know ?

In the seventh week after conception, networks of neurons produce brain waves that have been recorded as early as 6 ½ weeks after conception. The embryo spontaneously moves his arms, hands, and legs, and may even hiccup. The embryo’s heart now has all four chambers.

Did You Know ?

By the seventeenth and eighteenth week after gestation, the fetus shows a clear response to pain in multiple studies, and at least one brain pathway is mature enough to create a perception of pain. The fetus also practices breathing, crying, and breastfeeding in the womb. The fetal heart has beat over 20 million times and circulates about 55 quarts of blood per day.

Did You Know ?

In the eighth month of pregnancy the fetal brain is ready to learn! At 32 weeks after conception, neurons are creating 40,000 new connections, called synapses, every second! With repeated exposures, the fetus can learn flavors, nursery rhymes, songs, and even words that she will recognize after birth!

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review
Latest Research / Life & the Law

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review

This paper critically analyzes the FDA's 2021 REMS Review leading to the removal of the in-person dispensing requirement for mifepristone.

Zachary Sluzala,… Ingrid Skop,…
October 6, 2026
Inside The Government Decision That Opened Up Abortion Pill Floodgates
Latest Research / Abortion Drugs

Inside The Government Decision That Opened Up Abortion Pill Floodgates

The decision "fell well short" of the FDA's standards.

charlotte-lozier-institute Charlotte Lozier Institute
October 6, 2026
Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Latest Research / Life & the Law

Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

This paper critically analyzes the FDA's 2021 literature review that served as the basis for its controversial decision to remove…

Ingrid Skop,…
October 6, 2026
Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement
Latest Research / General

Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement

A new peer-reviewed article on the Food and Drug Administration’s (FDA) 2021 complete review of mifepristone’s Risk Evaluation and Mitigation…

charlotte-lozier-institute Charlotte Lozier Institute
October 6, 2026
Abortion Reporting: Kentucky (2025)
Latest Research / Maternal & Public Health

Abortion Reporting: Kentucky (2025)

In 2025, five brick-and-mortar abortions were reported in Kentucky by the state’s Cabinet for Health and Family Services. The data…

Elyse Gaitan Mia Steupert,…
October 5, 2026
Maternal & Public Health

Abortion Reporting: Alabama (2022)

Alabama’s 2022 abortion report was published online by the Alabama Department of Public Health in October 2023, showing that abortions decreased significantly from 2021.

Mia Steupert, M.A. Tessa Cox
November 6, 2023
Maternal & Public Health

Fact Sheet: Miscarriage Management with Mifepristone

If mifepristone is unavailable, patients will not suffer, for there are several other effective options available for treating a miscarriage. Fearmongering about an inability to treat miscarriages in the aftermath of Dobbs should be recognized for the ideologically driven, pro-abortion rhetoric that it is.

Ingrid Skop, M.D.,…
November 3, 2023
Maternal & Public Health

Abortion Reporting: Maine (2022)

Maine’s 2022 abortion report was published in August 2023. The report indicates that abortions increased from 2021 to 2022.

Mia Steupert, M.A. Tessa Cox
November 1, 2023
Maternal & Public Health

Abortion Reporting: Vermont (2021)

Vermont’s 2021 abortion statistics were published online as part of the state’s full vital statistics report in September 2023. The report is available on the website of the Vermont Department of Health.

Mia Steupert, M.A. Tessa Cox
October 31, 2023
Maternal & Public Health

Abortion Reporting: Texas (2022)

Texas’ 2022 abortion report was released by Texas Health and Human Services in September 2023, showing a significant drop in abortions from 2021.

Mia Steupert, M.A. Tessa Cox
October 31, 2023
Human Embryonic Stem Cell Research 25 Years On
Fetal Tissue, Stem Cells & Bioethics

Human Embryonic Stem Cell Research 25 Years On

Twenty-five years ago, scientists first isolated human embryonic stem cells (hESCs). Shortly after this development, the use of these stem cells in medical research had become a major public policy controversy in the United States.

Eugene C. Tarne
October 30, 2023
Maternal & Public Health

Abortion Reporting: Louisiana (2022)

Louisiana’s 2022 abortion report was published by the Louisiana Department of Health in June 2023. Parish and clinic data were provided to Charlotte Lozier Institute (CLI) by the Department of Health upon request. The report shows that abortions decreased markedly from 2021.

Mia Steupert, M.A. Tessa Cox
October 17, 2023
Maternal & Public Health

Abortion Reporting: Ohio (2022)

Ohio’s 2022 abortion report was published in September 2023 by the Ohio Department of Health. Abortions decreased in the state from 2021.

Mia Steupert, M.A. Tessa Cox
October 16, 2023

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image